Phytonutrients in the Treatment of Breast Cancer delves into the evolving role of phytonutrients as powerful therapeutic agents in the fight against breast cancer. This comprehensive book explores the molecular mechanisms by which bioactive compounds found in fruits, vegetables, and plant-based foods influence cancer progression, offering a promising approach to cancer prevention and treatment. Drawing on the latest research, it highlights how compounds such as flavonoids, carotenoids and polyphenols target key molecular pathways involved in cancer cell growth, metastasis, and resistance to chemotherapy.
Incorporating cutting-edge experimental and clinical data, this book provides a detailed examination of how specific phytonutrients can complement traditional cancer therapies. It presents a compelling case for the integration of these natural compounds into holistic treatment strategies, aimed at improving patient outcomes while minimizing side effects. The author addresses the potential of phytonutrients to support immune function, reduce inflammation, and enhance the efficacy of conventional treatments, positioning these dietary compounds as critical adjuncts in personalized cancer care.
Features:
- Covers the latest research on how phytonutrients contribute to breast cancer prevention and treatment
- Explains in-depth the molecular pathways through which phytonutrients exert their anti-cancer effects
- Provides practical applications for incorporating phytonutrient-rich foods into breast cancer treatment plans
- Discusses how consuming phytonutrients may reduce the risk of developing breast cancer
- Includes a comprehensive list of resources and references for further exploration into phytonutrient research
The book also emphasizes the growing importance of diet and nutrition in cancer prevention, offering practical insights for healthcare professionals, researchers, and patients alike. With a focus on the therapeutic potential of plant-based foods, Phytonutrients in the Treatment of Breast Cancer serves as an invaluable resource for those seeking to understand the molecular intricacies of cancer and explore innovative, integrative treatment options. Whether for clinical application or research exploration, this book provides a solid foundation for advancing the role of phytonutrients in breast cancer therapy.
Dr. Haroon Khan (Fellow Royal Society of Chemistry; Member European Association for Cancer Research) is a Professor at the Department of Pharmacy, Abdul Wali Khan University Mardan. Dr. Khan has got PhD degree from University of Peshawar in Pharmaceutical Sciences. He has more than twenty-three years’ experience in pharmacy teaching, research and professional expertise in various fields of pharmaceutical sciences. His research focus is phytomedicines/pharmacology. In this connection, he has already published 509 articles including Research, Reviews and Editorials in various national and international reputable journals. Prof. Khan is the editorial board member of a number of journals including Associate Editor in Phytomedicine and Frontiers in Nutrition, consulting editor of Pharmacological Research, Section Editor of Current Neuropharmacology, Current Molecular Pharmacology. The scientific contributions of Dr. Khan have been acknowledged by Pakistan Council for Science and Pakistan Council for Science and Technology (PCST), and awarded Research Productivity awards four times for the years 2011-2014. Dr. Khan is Clarivate Analytics Highly Cited Researchers. This clearly reflects the outstanding research potential of Dr. Khan acknowledged globally.
Dr. Muhammad Ajmal Shah is a registered pharmacist and an academic researcher. He obtained his PharmD and MPhil in Pharmacognosy degrees from Federal Urdu University, Karachi, Pakistan. He obtained his PhD in Pharmaceutical Sciences from Prince of Songkla University, Hat-Yai, Thailand by securing Thailand Education Hub for ASEAN Countries PhD Scholarship Award (TEH-AC 2014-17). He has published more than 100 scientific articles in well reputed international journals, edited one book with Elsevier and has authored over 60 chapters in different books published by Elsevier, Springer and other well recognized publishers. He has also been listed in Top 2% global research scientist’s category for the year 2024 as analysed and published by Stanford University, UK. He is a reviewer and an editorial board member of various reputed international journals. Dr. Shah is an active member of the American Society of Pharmacognosy, Phytochemical Society of Europe, American Society of Microbiology, and GA Society for Medicinal Plant and Natural Product Research Germany. Previously, he has worked as an assistant professor and head of department at the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan and currently he is working as an Assistant Professor at Department of Pharmacy, Hazara University, Mansehra, Pakistan. He is also an adjunct professor at Department of Pharmacy, Diponegoro University, Indonesia, Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Indonesia and Faculty of Pharmacy, Pancasila University Jakarta, Indonesia. His primary research interests include green extraction and enrichment of bioactive compounds, their isolation, and pharmacological evaluation in metabolic and aging-associated diseases.
Dr. Tarun Belwal is currently working at 7CNP, USA. Before this, Dr. Belwal worked at Texas A&M University, Texas, USA, the Department of Drug Science and Technology, University of Turin, Italy, and at the College of Biosystems Engineering and Food Science, Zhejiang University, China.
During his Ph.D., Dr. Belwal worked at G.B. Pant National Institute of Himalayan Environment (NIHE), Almora, Uttarakhand, India, on the utilization of natural products as nutraceutical agents and examined their functional activities, development of the plant in vitro cell culture, and advanced extraction techniques, for which he has awarded the prestigious ‘Governor award for Best Research’, by Uttarakhand Government, consequently for two years. He has completed a project as Principle Investigator (2018-20), funded by CPDSF, China. His excellent research credentials reflect over >100 peer-reviewed scientific publications, 15 book chapters, and 6 edited books with over more than 9000 citations. Dr. Belwal has guided several PhDs, postgraduates, and undergraduate students and jointly share the research outcomes. He also collaborated with several leading global researchers, which lead to fruitful collaborative outcomes.
PROF. DR. EDUARDO SOBARZO-SÁNCHEZMedicinal and Bioinorganic Chemistry Research GroupGrupo de Investigación “Química Médica y Bio-inorgánica” (QMEDBIN)Instituto de Investigación y DoctoradosFacultad de Medicina y Ciencias de la SaludUniversidad Central de Chile CHILE
Full professor and researcher at the Instituto de Investigación y Doctorados, Facultad de Medicina y Ciencias de la Salud at the Universidad Central de Chile (UCEN, Chile). He was professor and researcher at the University of Chile (Chile) and University of Santiago de Compostela (USC, Spain), wherein he continues as an associate researcher at the Faculty of Pharmacy (USC) in the field of Natural Products-Medicinal Chemistry against CNS diseases and experimental studies about drug delivery systems.
From these research lines, there have been generated more than 170 scientific articles of high impact index in the field of the Chemistry, Pharmacy and Nanotechnology compiled in several journals. On the base of the excellent experimental results, and of direct application in the scope of the health, such results have been protected in more than 9 (European) protection patents and PCT (Patent Cooperation Treaty) that cover the scope of the applied nanomedicine in neuro-degenerative and parasitic diseases. At the present time, he is International Referee of Research Projects in the fields of Biomedicine, in Argentina and Chile (FONCYT and FONDECYT, respectively), and Spain for the National Agency of Evaluation and Prospective (ANEP).
He is Editor / Editorial Board member of the following journals; Molecules, International Journal of Nanomedicine, Journal of Nanomedicine and Nanotechnology, Archives of Natural Biological Research, Frontiers in Pharmacology, Mini-Reviews in Medicinal Chemistry, Current Medicinal Chemistry, Oxidative Medicine and Cellular Longevity and Current Topics in Medicinal Chemistry.
Inside the research activities carried out, two main research lines can be described; 1) Synthesis of compounds from natural sources or synthetic ways with pharmacological activity (neuro-degenerative dysfunctions and behavioral disorders as Parkinson’s and Alzheimer’s diseases and depression-anxiety, respectively), and parasitic diseases (Malaria, Leishmania), and; 2) Synthesis of supramolecular system derived from natural/synthetic polymers for controlled release of drugs.
